Seneca Growth Capital VCT PLC (HYG) - Cash Flow Conversion Efficiency

Latest as of December 2024: -0.005x

Based on the latest financial reports, Seneca Growth Capital VCT PLC (HYG) has a cash flow conversion efficiency ratio of -0.005x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-70.00K ≈ $-8.52 USD) by net assets (GBX13.94 Million ≈ $1.70K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Seneca Growth Capital VCT PLC to measure how much of total assets are equity-financed.

Seneca Growth Capital VCT PLC - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Seneca Growth Capital VCT PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Seneca Growth Capital VCT PLC to evaluate the quality of earnings relative to operating cash generation.

Seneca Growth Capital VCT PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Seneca Growth Capital VCT PLC ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Nuvve Holding Corp
NASDAQ:NVVEW
2.691x
Ordinary Fully Paid Deferred Settlement
AU:CNJDG
-0.239x
RPCG PCL F
F:R4Q
0.061x
GCM Grosvenor Inc
NASDAQ:GCMGW
20.878x
Innoviz Technologies Ltd
NASDAQ:INVZW
-0.153x
Jack Nathan Medical Corp
V:JNH
0.214x
Seelos Therapeutics, Inc.
NASDAQ:SEELQ
0.035x
Godha Cabcon & Insulation Limited
NSE:GODHA
-1.064x

Annual Cash Flow Conversion Efficiency for Seneca Growth Capital VCT PLC (2002–2024)

The table below shows the annual cash flow conversion efficiency of Seneca Growth Capital VCT PLC from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Seneca Growth Capital VCT PLC market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 GBX13.94 Million
≈ $1.70K
GBX-257.00K
≈ $-31.27
-0.018x +32.14%
2023-12-31 GBX16.89 Million
≈ $2.06K
GBX-459.00K
≈ $-55.85
-0.027x -2.42%
2022-12-31 GBX18.13 Million
≈ $2.21K
GBX-481.00K
≈ $-58.52
-0.027x -63.63%
2021-12-31 GBX17.76 Million
≈ $2.16K
GBX-288.00K
≈ $-35.04
-0.016x +9.99%
2020-12-31 GBX10.77 Million
≈ $1.31K
GBX-194.00K
≈ $-23.60
-0.018x -9.44%
2019-12-31 GBX8.38 Million
≈ $1.02K
GBX-138.00K
≈ $-16.79
-0.016x -44.12%
2018-12-31 GBX9.28 Million
≈ $1.13K
GBX-106.00K
≈ $-12.90
-0.011x +45.72%
2017-12-31 GBX5.18 Million
≈ $630.26
GBX-109.00K
≈ $-13.26
-0.021x +11.57%
2016-12-31 GBX5.55 Million
≈ $674.91
GBX-132.00K
≈ $-16.06
-0.024x +4.05%
2015-12-31 GBX6.13 Million
≈ $745.72
GBX-152.00K
≈ $-18.49
-0.025x -133.18%
2014-12-31 GBX7.33 Million
≈ $892.34
GBX-78.00K
≈ $-9.49
-0.011x +59.38%
2013-12-31 GBX7.83 Million
≈ $952.56
GBX-205.00K
≈ $-24.94
-0.026x -60.01%
2012-12-31 GBX9.59 Million
≈ $1.17K
GBX-157.00K
≈ $-19.10
-0.016x -141.15%
2011-12-31 GBX5.73 Million
≈ $697.54
GBX228.00K
≈ $27.74
0.040x +159.77%
2010-12-31 GBX6.28 Million
≈ $764.34
GBX-418.00K
≈ $-50.86
-0.067x -2445.99%
2009-12-31 GBX7.40 Million
≈ $900.85
GBX21.00K
≈ $2.56
0.003x +108.45%
2008-12-31 GBX5.16 Million
≈ $627.21
GBX-173.00K
≈ $-21.05
-0.034x -26.76%
2007-12-31 GBX4.61 Million
≈ $560.66
GBX-122.00K
≈ $-14.84
-0.026x +70.85%
2006-12-31 GBX4.29 Million
≈ $522.46
GBX-390.00K
≈ $-47.45
-0.091x -142.16%
2005-12-31 GBX5.68 Million
≈ $690.97
GBX-213.00K
≈ $-25.92
-0.038x -152.01%
2004-12-31 GBX6.29 Million
≈ $765.92
GBX454.00K
≈ $55.24
0.072x +489.40%
2003-12-31 GBX6.91 Million
≈ $840.87
GBX-128.00K
≈ $-15.57
-0.019x -135.08%
2002-12-31 GBX6.73 Million
≈ $818.48
GBX-53.00K
≈ $-6.45
-0.008x --

About Seneca Growth Capital VCT PLC

LSE:HYG UK Asset Management
Market Cap
$69.12
GBX568.08K GBX
Market Cap Rank
#31882 Global
#1322 in UK
Share Price
GBX0.07
Change (1 day)
-99.00%
52-Week Range
GBX0.06 - GBX9.00
All Time High
GBX33.12
About

Seneca Growth Capital VCT plc is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies. The fund seeks to invest in the United Kingdom, IIe-de-France, Burgundy, France, European Developed Markets. It typically invests in companies with sales greater than £10 million ($11.90 million), gro… Read more